The Berkeley Approach
4myheart Program
Test Descriptions
Webinars
BHL University
Clinical References
Get Started
Support & FAQs
What is Heart Disease?
Why would my doctor
order a Berkeley?
Test Results 101
4myheart Program
Support & FAQs
Company Overview
Our History
Our Laboratory
Events
Announcements
Insurance Providers
Careers
Go to 4myheart.com
4myheart Testimonial Video
4myheart Program
Contact Information
4myheart Centers
The Berkeley Approach
4myheart Program
Test Descriptions
Sample Test Report
BHL University
Clinical References
Get Started
Support & FAQs
4myheart.com
is our interactive website that offers heart health resources, opportunities to interact with a Berkeley HeartLab Clinical Educator, test results, and tools to record and track progress toward patients' goals.
Clinical Implications Reference Manual
To view the online version use the links below.
Introduction to the Second Edition
Clinical Perspective
Revisiting Cardiovascular Biomarkers and Risk Factors — An Update on Clinical Utility
Lipoprotein Metabolism
Low Density Lipoprotein Subclass Separation
Apolipoprotein B (apoB), Low Density Lipoprotein Cholesterol (LDL-C) and Atherogenic Risk
Atherogenic Low Density Lipoprotein Subclass Quantitation (Q-LDL)
High Density Lipoprotein Cholesterol (HDL-C)
Variable Character of High Density Lipoprotein (HDL) Populations
High Density Lipoprotein (HDL) Subclasses
Triglyceride
Lipoprotein-associated Phospholipase A
2
(Lp-PLA
2
)
High Sensitivity C-Reactive Protein (hs-CRP)
Fibrinogen
Homocysteine (Hcy)
Lipoprotein(a)[Lp(a)]
Insulin, Glucose, and Hemoglobin A1c Insulin Resistance, Metabolic Syndrome, Diabetes Mellitus and Cardiovascular Disease
N-terminal fragment of the prohormone B-type natriuretic peptide (NT-proBNP) — a Functional Cardiac Biomarker
Apolipoprotein E (apoE) Genotype for Cardiovascular Disease Management